TAC files a complaint with the Competition Commission concerning the conduct and excessive pricing of essential ARV medicines by multi-national pharmaceutical giants Boehringer Ingelheim and GlaxoSmithKline.
- Minister Patel must make COVID-19 medicines accessible to all by taking steps to #FixThePatentLaws
- Fix the Patent Laws Coalition supports South Africa and India’s proposal to facilitate access to COVID-19 vaccines
- More than 80 academics, researchers and teachers call on President Ramaphosa to Fix the Patent Laws
- South Africa’s patent laws threaten access to future COVID-19 medicines
- COVID-19: The time for procrastination over patents is over